| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.800.975 | 3.389.223 | 3.878.822 | 6.198.558 | 6.009.320 | 3.643.852 | 3.973.524 | 5.494.127 | 7.787.272 | 8.846.574 |
| Total Income - EUR | 3.389.947 | 3.783.309 | 4.811.726 | 6.135.151 | 6.256.010 | 3.981.851 | 4.306.852 | 6.006.172 | 8.204.990 | 9.090.992 |
| Total Expenses - EUR | 4.702.975 | 4.995.093 | 5.960.929 | 6.693.514 | 7.332.041 | 4.018.983 | 4.236.629 | 5.871.335 | 8.082.594 | 8.784.652 |
| Gross Profit/Loss - EUR | -1.313.028 | -1.211.784 | -1.149.204 | -558.363 | -1.076.031 | -37.132 | 70.223 | 134.837 | 122.395 | 306.340 |
| Net Profit/Loss - EUR | -1.313.028 | -1.211.784 | -1.256.165 | -558.363 | -1.076.031 | -37.132 | 70.223 | 134.837 | 122.395 | 283.387 |
| Employees | 74 | 87 | 102 | 105 | 96 | 69 | 68 | 72 | 88 | 90 |
Check the financial reports for the company - Enrx S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.498.035 | 2.680.092 | 2.360.077 | 2.197.292 | 1.170.477 | 1.030.816 | 900.322 | 965.295 | 1.312.555 | 1.380.375 |
| Current Assets | 2.495.755 | 1.401.958 | 2.210.316 | 2.618.307 | 2.818.727 | 2.119.225 | 2.260.512 | 2.773.134 | 4.105.656 | 5.525.422 |
| Inventories | 825.811 | 770.819 | 1.515.770 | 1.316.869 | 851.795 | 1.159.135 | 1.618.090 | 1.862.267 | 2.451.118 | 2.139.370 |
| Receivables | 919.173 | 543.085 | 478.254 | 924.699 | 1.233.258 | 618.445 | 396.502 | 177.398 | 1.039.109 | 3.187.329 |
| Cash | 750.772 | 88.055 | 216.292 | 376.740 | 733.675 | 341.646 | 245.921 | 733.469 | 615.429 | 198.723 |
| Shareholders Funds | 507.580 | -488.820 | -1.736.713 | 429.722 | -660.850 | 1.415.371 | 1.454.207 | 1.593.556 | 1.711.118 | 1.984.942 |
| Social Capital | 5.174.353 | 5.121.582 | 5.034.916 | 7.660.900 | 7.512.538 | 2.307.573 | 2.256.400 | 2.263.401 | 2.256.537 | 2.243.926 |
| Debts | 3.617.393 | 4.489.134 | 5.856.207 | 4.027.544 | 4.350.173 | 1.505.203 | 1.477.837 | 1.954.240 | 3.472.985 | 4.535.678 |
| Income in Advance | 716.561 | 428.559 | 367.944 | 291.073 | 232.945 | 202.667 | 167.928 | 143.838 | 120.869 | 101.314 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2841 - 2841" | |||||||||
| CAEN Financial Year |
2841
|
|||||||||
Comments - Enrx S.r.l.